Novartis reclaims tk technology

Nat Biotechnol. 1997 Mar;15(3):211. doi: 10.1038/nbt0397-211a.
No abstract available

Publication types

  • News

MeSH terms

  • Brain Neoplasms / therapy
  • Clinical Trials as Topic
  • Female
  • Genetic Therapy*
  • Genetic Vectors
  • Glioblastoma / therapy
  • Humans
  • Ovarian Neoplasms / therapy
  • Retroviridae / genetics
  • Thymidine Kinase / genetics*
  • United States

Substances

  • Thymidine Kinase